Skip to Content

Desloratadine Pregnancy and Breastfeeding Warnings

Desloratadine is also known as: Aerius, Clarinex, Clarinex Reditabs, Neoclarityn

Medically reviewed by Drugs.com. Last updated on Apr 10, 2019.

Desloratadine Pregnancy Warnings

Animal studies have revealed evidence of decreased body weight, slow righting reflex, increased pre-implantation losses, and decreased implantations and fetuses occurred at doses at least 50 times the AUC in humans at the recommended daily oral dose. There are no controlled data in human pregnancy.

AU TGA pregnancy category B1: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have not shown evidence of an increased occurrence of fetal damage.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Use is recommended only if clearly needed and the benefit outweighs the risk.

AU TGA pregnancy category: B1
US FDA pregnancy category: C

See references

Desloratadine Breastfeeding Warnings

When 6 patients were given 40 mg of the parent compound, the calculated expected dose of this drug in milk was approximately 0.42% of the maternal weight-adjusted dose, and the Cmax was 16 mcg/mL.

Use is not recommended and a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Yes

Comments:
-The effects in the nursing infant are unknown.
-The American Academy of Pediatrics has classified the parent compound (loratadine) as compatible with breastfeeding.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Clarinex (desloratadine)." Schering Corporation, Kenilworth, NJ.

References for breastfeeding information

  1. "Product Information. Clarinex (desloratadine)." Schering Corporation, Kenilworth, NJ.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  4. Briggs GG, Freeman RK. "Drugs in Pregnancy and Lactation. 10th ed." Philadelphia, PA: Wolters Kluwer Health (2015):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide